Radiomics of hepatocellular carcinoma
The diagnosis of hepatocellular carcinoma relies largely on non-invasive imaging, and is
well suited for radiomics analysis. Radiomics is an emerging method for quantification of …
well suited for radiomics analysis. Radiomics is an emerging method for quantification of …
Radiomics of hepatocellular carcinoma: promising roles in patient selection, prediction, and assessment of treatment response
Radiomics refers to the process of conversion of conventional medical images into
quantifiable data (“features”) which can be further mined to reveal complex patterns and …
quantifiable data (“features”) which can be further mined to reveal complex patterns and …
Radiomics analysis based on contrast-enhanced MRI for prediction of therapeutic response to transarterial chemoembolization in hepatocellular carcinoma
Y Zhao, N Wang, J Wu, Q Zhang, T Lin, Y Yao… - Frontiers in …, 2021 - frontiersin.org
Purpose To investigate the role of contrast-enhanced magnetic resonance imaging (CE-
MRI) radiomics for pretherapeutic prediction of the response to transarterial …
MRI) radiomics for pretherapeutic prediction of the response to transarterial …
Efficacy and safety profile of drug-eluting beads transarterial chemoembolization by CalliSpheres® beads in Chinese hepatocellular carcinoma patients
GH Zhou, J Han, JH Sun, YL Zhang, TY Zhou, CH Nie… - BMC cancer, 2018 - Springer
Background This study aimed to investigate the efficacy and safety of drug eluting beads
transarterial chemoembolization (DEB-TACE) treatment by CalliSpheres® in Chinese …
transarterial chemoembolization (DEB-TACE) treatment by CalliSpheres® in Chinese …
Transarterial‐chemoembolization remains an effective therapy for intermediate‐stage hepatocellular carcinoma with preserved liver function
N Saito, T Tanaka, H Nishiohuku, T Sato… - Hepatology …, 2020 - Wiley Online Library
Aim To evaluate outcomes as well as prognostic factors of transarterial chemoembolization
(TACE) in intermediate‐stage hepatocellular carcinoma (HCC) with preserved liver function …
(TACE) in intermediate‐stage hepatocellular carcinoma (HCC) with preserved liver function …
[HTML][HTML] The comprehensive analysis of efficacy and safety of CalliSpheres® drug-eluting beads transarterial chemoembolization in 367 liver cancer patients: A …
Z Peng, G Cao, Q Hou, L Li, S Ying, J Sun… - Oncology …, 2020 - ncbi.nlm.nih.gov
This study aimed to investigate the efficacy, safety, and prognostic factors of drug-eluting
beads transarterial chemoembolization (DEB-TACE) in treating Chinese patients with liver …
beads transarterial chemoembolization (DEB-TACE) in treating Chinese patients with liver …
Predictive factors of complete response to transarterial chemoembolization in intermediate stage hepatocellular carcinoma beyond up-to-7 criteria
N Saito, H Nishiofuku, T Sato, S Maeda, K Minamiguchi… - Cancers, 2023 - mdpi.com
Simple Summary To date, the indication for transarterial chemoembolization (TACE) of
intermediate stage hepatocellular carcinoma (HCC) with a high tumor burden remains …
intermediate stage hepatocellular carcinoma (HCC) with a high tumor burden remains …
Deep learning–based automatic segmentation of meningioma from T1-weighted contrast-enhanced MRI for preoperative meningioma differentiation using radiomic …
L Yang, T Wang, J Zhang, S Kang, S Xu, K Wang - BMC Medical Imaging, 2024 - Springer
Background This study aimed to establish a dedicated deep-learning model (DLM) on
routine magnetic resonance imaging (MRI) data to investigate DLM performance in …
routine magnetic resonance imaging (MRI) data to investigate DLM performance in …
[HTML][HTML] A novel pre-treatment model predicting risk of developing refractoriness to transarterial chemoembolization in unresectable hepatocellular carcinoma
K Hu, S Lu, M Li, F Zhang, B Tang, J Yuan… - Journal of …, 2020 - ncbi.nlm.nih.gov
Background and aim: Refractoriness to transarterial chemoembolization is common during
the therapeutic process of hepatocellular carcinoma, which is an intractable issue and may …
the therapeutic process of hepatocellular carcinoma, which is an intractable issue and may …
[HTML][HTML] Transarterial chemoembolization: a favorable postoperative management to improve prognosis of hepatitis B virus-associated intrahepatic …
S Jeong, BO Zheng, J Wang, J Chi, Y Tong… - … Journal of Biological …, 2017 - ncbi.nlm.nih.gov
Background: There is no information regarding transarterial chemoembolization (TACE) as a
postoperative management after hepatic resection for patients with hepatitis B virus (HBV) …
postoperative management after hepatic resection for patients with hepatitis B virus (HBV) …